Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
REVENUES:		$ 6,555		$ 10,361
OPERATING EXPENSES:
Research and development	2,630,368	2,445,770	6,079,508	4,789,083
General and administrative	980,070	1,001,538	2,023,580	2,062,554
Total operating expenses	3,610,438	3,447,308	8,103,088	6,851,637
Loss from operations	(3,610,438)	(3,440,753)	(8,103,088)	(6,841,276)
OTHER INCOME (EXPENSE):
Investment income	4,931	13,016	10,250	27,387
Interest expense	(954)	(1,360)	(2,805)	(3,642)
Increase in fair value of warrants				(7,069,165)
Gain on disposition of supplies and equipment				4,620
Total other income (expense), net	3,977	11,656	7,445	(7,040,800)
Loss before income taxes	(3,606,461)	(3,429,097)	(8,095,643)	(13,882,076)
Income tax benefit		1,753,208		1,753,208
NET LOSS	$ (3,606,461)	$ (1,675,889)	$ (8,095,643)	$ (12,128,868)
Basic and diluted net loss per common share	$ (0.03)	$ (0.02)	$ (0.08)	$ (0.14)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share	106,668,186	106,424,443	106,638,953	89,046,806